After the FDA crackdown, here's how some companies are still selling GLP-1s
Microdosing now commonly refers to low-dose GLP-1 weight-loss medications sold via compounded formulations and telehealth, raising safety and regulatory concerns.
Novo Nordisk Notches a Court Win Against Wegovy and Ozempic Compounders - MedCity News
Compounded versions of Novo Nordisk's Wegovy and Ozempic must halt production following a federal court ruling upholding FDA's assessed resolution of shortages.